Medical Virology 2021

This section of the website is currently for medical virology trainees who start specialty training from August 2021.

Medical Virology Curriculum 2021

The new 2021 curricula will be assessed by High Level Outcomes, which are included in the form of Capabilities in Practice (CiPs), CiPs describe the professional tasks or work within the scope of postgraduate pathology training; they are based on the format of entrustable professional activities, which are a method of using the professional judgement of appropriately trained assessors as a key aspect of the validity of assessment and a defensible way of forming global judgements of professional performance.

The 2021 Infectious Diseases and Tropical Medicine curricula can be found on the JRCPTB website.

Assessment Strategy

The Royal College of Pathologists' assessment strategy identifies the broad approach and purpose of our programme of assessment and describes the approach for the medical pathology specialties regulated by the General Medical Council.

ARCP Decision Aid

The decision aids provide guidance on the requirements to be achieved for a satisfactory ARCP outcome at the end of each training year.

CiP Guidance

The purpose of this guidance is to ensure that trainers and educational supervisors are consistent in their approach to assessing each CiPs. The guidance breaks down each the CiP down into its constituent parts and helps trainers to recognise the minimum level of knowledge, skills and attitudes that should be demonstrated for an entrustment decision to be made. The descriptors and evidence listed are not intended to be comprehensive but guide the trainer and trainee on what satisfactory performance will look like.

The CiP guidance will be available shortly.

Rough Guide to Implementation - Infection Specialties curricula

The following guide has been developed to support trainees, educational supervisors and training programme directors. It should be used with the 2021 curriculum.

Infection Curricula Launch Event

A virtual curricula launch event was held with the aim to introduce the new Infection curricula to trainers and educational supervisors and to understand Capabilities in Practice and how they will inform assessment of trainees.

Attendees were able to ask questions throughout the webinar. Below are the questions that were asked and answered during the event.

Questions and Answers


Has there been any discussion about having a CCT for Infection Prevention and Control?

If trainees do stage 1 training, then do ID/MM, do they get triple accredited?

For Group 2 Dual trainees in ID/MM or ID/MV, what is the exact split to cover curricula in dual specialities- is it half and half of the 3 years

Is there national oversight and decision making about the proportion of NTN’s in the different CCT pathways? Who decides how many NTN’s are needed in ID/IM versus the pure MM for example?

Do trainees need to know which infection stem they want to train in when they start IMT? Or can they drop the 3rd year if they then want to train in ID/MMV?

For tropical medicine, will trainees have to go abroad for a year to achieve this CIP?

Some clarity about how IM is incorporated for ID IM trainees as CIT is the same for both ID MM/MV and ID IM and yet ID IM has to include IM CiPs?

Are 2 Educational Supervisor reports required for an ID/IM trainee during CIT when they are in the lab for a year and not doing any IM at all?

Can an IDMM consultant be the ES for GIM for IDGIM trainees?

A LTFT trainee could enter their final year of training in July 2022 and not have a CCT before August 2023, so what would they do?

Are there transition arrangements for trainees without MRCP still on modified curriculum and also trainees in final year but who end up still in training in Aug 23?

The descriptor required for CiP7 (dealing with imported infection) for a single CCT MM trainee in Yr 2 of HIT (i.e. at the end of pre-CCT training) is only 2 (entrusted to act with direct supervision)

Are there transition arrangements for trainees without MRCP still on modified curriculum and also trainees in final year but who end up still in training in Aug 23?

Will there be PYR’s for trainees in MM or MV as well as for the ID/ IM aspects?

What does entrustment level 4 mean in practice? All trainees are supervised to some extent, even during acting up periods.

Are MM or MV single CCT trainees able to join the programme from the ACCS route?

Should we be encouraging trainees who are switching to new curriculum in 2022, to "prepare" in the year 2021-22? Can they have access to the new e-portfolio early if they want?

We need clarity on the qualifications of the trainer to provide an ES report for each specialty

The table showed CIT trainees to be at entrustable level 2 requiring direct clinical supervision. How does this work with on-call?

Are the mono-specialties of microbiology and virology coming back. We were made to believe that mono-specialties would cease to exist


I am interested to hear of changes to FRCPath Microbiology Part 2 exam